Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer

Qingchun Cai, Zhenwen Zhao, Caryl Antalis, Libo Yan, Giuseppe Del Priore, Ali Hassan Hamed, Frederick Stehman, Jeanne Schilder, Yan Xu

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Ascites in epithelial ovarian cancer (EOC) promotes tumor development by mechanisms that are incompletely understood. Lysophosphatidic acid (LPA), a major tumor-promoting factor in EOC ascites, is an enzymatic product of autotaxin (ATX) and phospholipase A2 (PLA2) enzymes. The contribution of PLA2 activities to ovarian tumorigenesis was investigated. The quantitative measurement of PLA2activities in ascites and tissues, as well as assay conditions selective for PLA2 subtypes, were optimized and validated. PLA2 activities correlated with tumor-promoting activates in cell-based and in vivo assays. High activities consistent with both cytosolic and calcium-independent PLA2 were found in human EOC ascites for the first time. Elevated PLA2 and ATX activities were also observed in EOC compared to benign tumors and normal tissues. Cell-free and vesicle-free (S4) human EOC ascites potently promoted proliferation, migration, and invasion of human EOC cells in a PLA 2-dependent manner. LPA mediated a significant part of the cell-stimulating effects of ascites. S4 ascites stimulated tumorigenesis/ metastasis in vivo, and methyl arachidonyl fluorophosphonate was highly effective in inhibiting EOC metastasis in mouse xenograft models. PLA 2activity was found in conditioned media from both EOC cells and macrophages. Collectively, our work implies that PLA2 activity is a potential marker and therapeutic target in EOC.

Original languageEnglish (US)
Pages (from-to)3306-3320
Number of pages15
JournalFASEB Journal
Volume26
Issue number8
DOIs
StatePublished - Aug 1 2012

Fingerprint

Secretory Phospholipase A2
Phospholipases A2
Ascites
Tumors
Assays
Calcium-Independent Phospholipase A2
Therapeutics
Tissue
Macrophages
Neoplasms
Carcinogenesis
Conditioned Culture Medium
Heterografts
Neoplasm Metastasis
Ovarian epithelial cancer
Enzymes

Keywords

  • Ascites
  • Autotaxin
  • Methyl arachidonyl fluorophosphonate
  • Migration

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer. / Cai, Qingchun; Zhao, Zhenwen; Antalis, Caryl; Yan, Libo; Del Priore, Giuseppe; Hamed, Ali Hassan; Stehman, Frederick; Schilder, Jeanne; Xu, Yan.

In: FASEB Journal, Vol. 26, No. 8, 08.2012, p. 3306-3320.

Research output: Contribution to journalArticle

Cai, Qingchun ; Zhao, Zhenwen ; Antalis, Caryl ; Yan, Libo ; Del Priore, Giuseppe ; Hamed, Ali Hassan ; Stehman, Frederick B. ; Schilder, Jeanne M. ; Xu, Yan. / Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer. In: FASEB Journal. 2012 ; Vol. 26, No. 8. pp. 3306-3320.
@article{0e2bb34e0bbf4297b4ffac41c1b3f493,
title = "Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer",
abstract = "Ascites in epithelial ovarian cancer (EOC) promotes tumor development by mechanisms that are incompletely understood. Lysophosphatidic acid (LPA), a major tumor-promoting factor in EOC ascites, is an enzymatic product of autotaxin (ATX) and phospholipase A2 (PLA2) enzymes. The contribution of PLA2 activities to ovarian tumorigenesis was investigated. The quantitative measurement of PLA2activities in ascites and tissues, as well as assay conditions selective for PLA2 subtypes, were optimized and validated. PLA2 activities correlated with tumor-promoting activates in cell-based and in vivo assays. High activities consistent with both cytosolic and calcium-independent PLA2 were found in human EOC ascites for the first time. Elevated PLA2 and ATX activities were also observed in EOC compared to benign tumors and normal tissues. Cell-free and vesicle-free (S4) human EOC ascites potently promoted proliferation, migration, and invasion of human EOC cells in a PLA 2-dependent manner. LPA mediated a significant part of the cell-stimulating effects of ascites. S4 ascites stimulated tumorigenesis/ metastasis in vivo, and methyl arachidonyl fluorophosphonate was highly effective in inhibiting EOC metastasis in mouse xenograft models. PLA 2activity was found in conditioned media from both EOC cells and macrophages. Collectively, our work implies that PLA2 activity is a potential marker and therapeutic target in EOC.",
keywords = "Ascites, Autotaxin, Methyl arachidonyl fluorophosphonate, Migration",
author = "Qingchun Cai and Zhenwen Zhao and Caryl Antalis and Libo Yan and {Del Priore}, Giuseppe and Hamed, {Ali Hassan} and Frederick Stehman and Jeanne Schilder and Yan Xu",
year = "2012",
month = "8",
doi = "10.1096/fj.12-207597",
language = "English",
volume = "26",
pages = "3306--3320",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "8",

}

TY - JOUR

T1 - Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer

AU - Cai, Qingchun

AU - Zhao, Zhenwen

AU - Antalis, Caryl

AU - Yan, Libo

AU - Del Priore, Giuseppe

AU - Hamed, Ali Hassan

AU - Stehman, Frederick B.

AU - Schilder, Jeanne M.

AU - Xu, Yan

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Ascites in epithelial ovarian cancer (EOC) promotes tumor development by mechanisms that are incompletely understood. Lysophosphatidic acid (LPA), a major tumor-promoting factor in EOC ascites, is an enzymatic product of autotaxin (ATX) and phospholipase A2 (PLA2) enzymes. The contribution of PLA2 activities to ovarian tumorigenesis was investigated. The quantitative measurement of PLA2activities in ascites and tissues, as well as assay conditions selective for PLA2 subtypes, were optimized and validated. PLA2 activities correlated with tumor-promoting activates in cell-based and in vivo assays. High activities consistent with both cytosolic and calcium-independent PLA2 were found in human EOC ascites for the first time. Elevated PLA2 and ATX activities were also observed in EOC compared to benign tumors and normal tissues. Cell-free and vesicle-free (S4) human EOC ascites potently promoted proliferation, migration, and invasion of human EOC cells in a PLA 2-dependent manner. LPA mediated a significant part of the cell-stimulating effects of ascites. S4 ascites stimulated tumorigenesis/ metastasis in vivo, and methyl arachidonyl fluorophosphonate was highly effective in inhibiting EOC metastasis in mouse xenograft models. PLA 2activity was found in conditioned media from both EOC cells and macrophages. Collectively, our work implies that PLA2 activity is a potential marker and therapeutic target in EOC.

AB - Ascites in epithelial ovarian cancer (EOC) promotes tumor development by mechanisms that are incompletely understood. Lysophosphatidic acid (LPA), a major tumor-promoting factor in EOC ascites, is an enzymatic product of autotaxin (ATX) and phospholipase A2 (PLA2) enzymes. The contribution of PLA2 activities to ovarian tumorigenesis was investigated. The quantitative measurement of PLA2activities in ascites and tissues, as well as assay conditions selective for PLA2 subtypes, were optimized and validated. PLA2 activities correlated with tumor-promoting activates in cell-based and in vivo assays. High activities consistent with both cytosolic and calcium-independent PLA2 were found in human EOC ascites for the first time. Elevated PLA2 and ATX activities were also observed in EOC compared to benign tumors and normal tissues. Cell-free and vesicle-free (S4) human EOC ascites potently promoted proliferation, migration, and invasion of human EOC cells in a PLA 2-dependent manner. LPA mediated a significant part of the cell-stimulating effects of ascites. S4 ascites stimulated tumorigenesis/ metastasis in vivo, and methyl arachidonyl fluorophosphonate was highly effective in inhibiting EOC metastasis in mouse xenograft models. PLA 2activity was found in conditioned media from both EOC cells and macrophages. Collectively, our work implies that PLA2 activity is a potential marker and therapeutic target in EOC.

KW - Ascites

KW - Autotaxin

KW - Methyl arachidonyl fluorophosphonate

KW - Migration

UR - http://www.scopus.com/inward/record.url?scp=84864740329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864740329&partnerID=8YFLogxK

U2 - 10.1096/fj.12-207597

DO - 10.1096/fj.12-207597

M3 - Article

C2 - 22767227

AN - SCOPUS:84864740329

VL - 26

SP - 3306

EP - 3320

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 8

ER -